- Home
- TLSI vs SNWV Comparison
TLSI vs SNWV Comparison
Compare TLSI & SNWV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- SNWV
- Stock Information
- Founded
- TLSI 2010
- SNWV 2004
- Country
- TLSI United States
- SNWV United States
- Employees
- TLSI N/A
- SNWV N/A
- Industry
- TLSI Medical Specialities
- SNWV
- Sector
- TLSI Health Care
- SNWV
- Exchange
- TLSI Nasdaq
- SNWV NYSE
- Market Cap
- TLSI 204.0M
- SNWV 234.2M
- IPO Year
- TLSI N/A
- SNWV N/A
- Fundamental
- Price
- TLSI $5.54
- SNWV $33.30
- Analyst Decision
- TLSI Strong Buy
- SNWV
- Analyst Count
- TLSI 5
- SNWV 0
- Target Price
- TLSI $10.90
- SNWV N/A
- AVG Volume (30 Days)
- TLSI 39.7K
- SNWV 63.4K
- Earning Date
- TLSI 08-13-2025
- SNWV 08-11-2025
- Dividend Yield
- TLSI N/A
- SNWV N/A
- EPS Growth
- TLSI N/A
- SNWV N/A
- EPS
- TLSI N/A
- SNWV N/A
- Revenue
- TLSI $32,141,000.00
- SNWV $36,190,000.00
- Revenue This Year
- TLSI $55.52
- SNWV N/A
- Revenue Next Year
- TLSI $54.76
- SNWV N/A
- P/E Ratio
- TLSI N/A
- SNWV N/A
- Revenue Growth
- TLSI 46.20
- SNWV 61.50
- 52 Week Low
- TLSI $3.50
- SNWV $5.18
- 52 Week High
- TLSI $6.08
- SNWV $39.50
- Technical
- Relative Strength Index (RSI)
- TLSI 53.07
- SNWV N/A
- Support Level
- TLSI $5.18
- SNWV N/A
- Resistance Level
- TLSI $5.54
- SNWV N/A
- Average True Range (ATR)
- TLSI 0.32
- SNWV 0.00
- MACD
- TLSI 0.01
- SNWV 0.00
- Stochastic Oscillator
- TLSI 82.81
- SNWV 0.00
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About SNWV SANUWAVE HEALTH INC
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.